Abstract:Insulin resistance, as seen in type 2 diabetes, has been shown to increase the risk of late onset Alzheimer's Disease (AD) by as much as two-fold. In AD patients, characteristic findings are seen with structural magnetic resonance imaging (MRI) including global atrophy as well as regional reductions in gray matter volume (GMV) in the hippocampus, precuneus, posterior cingulate gyrus, parietotemporal, prefrontal, and orbitofrontal cortices. Additionally, negative correlations between peripheral insulin levels and regional GMV are seen in insulin resistant subjects in the middle temporal gyrus. The current study investigated whether elevated fasting glucose (FSG) levels were associated with lower GMV in brain areas that have been preferentially affected by AD. This association difference was further investigated between carrier and non-carrier (NC) groups of the apolipoprotein E (APOE) ε4 allele, a genetic risk factor for late onset AD. Statistical Parametric Mapping (SPM), an automated brain imaging analysis computer package, was used to spatially normalize individual brains to a standard brain template, to obtain GMV maps from structural MRI, and to examine the correlations between higher FSG levels and lower structural MRI GMV measurements in 118 cognitively normal, non-diabetic individuals 64±6 years of age (59ε4 carriers and 59 NCs). A significance threshold of p = .005 was set for all imaging related analyses. As predicted, significant correlations were seen between higher levels of FSG and lower GMV in AD-affected regions including the left inferior orbitofrontal cortex, parietal, and occipital lobes and the left and right frontal and temporal lobes. Negative correlations between FSG and regional GMV in the middle temporal gyri confirmed findings seen in insulin resistant subjects. Additionally, these associations in AD-related areas are seen in both carriers and NC. Higher FSG levels in cognitively normal, non-diabetic, older adults are associated with lower GMV in AD related brain areas, confirming that elevated FSG may be associated with AD risk, independent of APOE ε4 status. Lastly, this study encourages the consideration of elevated FSG and other indicators of glucose control as targets for AD prevention trials, complementing the findings previously established with fluorodeoxyglucose positron emission tomography neuroimaging.

Glucose metabolism and smaller hippocampal volume in elderly people with normal cognitive function

Visit-to-visit HbA1c Variability, Dementia, and Hippocampal Atrophy among Adults Without Diabetes

P2‐417: reduced posterior hippocampus volume may mediate executive function impairment in subjects with pre‐diabetes status

Memory dysfunction in type 2 diabetes mellitus correlates with reduced hippocampal CA1 and subiculum volumes.

High “Normal” Blood Glucose Is Associated with Decreased Brain Volume and Cognitive Performance in the 60s: The PATH through Life Study

Hippocampal subfields atrophy contribute more to cognitive impairment in middle-aged patients with type 2 diabetes rather than microvascular lesions

Individuals in the Prediabetes Stage Exhibit Reduced Hippocampal Tail Volume and Executive Dysfunction.

Brain imaging evidence of preclinical Alzheimer's disease in normal aging

The association of prediabetes and type 2 diabetes with hippocampal subfields volume: The Maastricht study

P3‐119: Higher blood glucose is associated with dementia among Chinese elderly independent of vascular risk factors and white matter hyperintensity volume: findings from SCOBHI

Glucose Transport and Utilization in the Hippocampus: From Neurophysiology to Diabetes-Related Development of Dementia

Individual and Combined Associations of Glucose Metabolic Components With Cognitive Function Modified by Obesity

Hippocampal volume reduction is associated with direct measure of insulin resistance in adults

Global brain atrophy but not hippocampal atrophy is related to type 2 diabetes

Association of impaired fasting glucose and Type 2 Diabetes Mellitus with brain volume changes in Alzheimer’s Disease patients analyzed by MRI: a retrospective study

Association Between Higher Fasting Serum Glucose Levels and the Pattern of Lower Regional Gray Matter Volumes in Cognitively Normal Adults

Region-specific Hippocampal Atrophy is Correlated with Poor Glycemic Control in Type 2 Diabetes: a Cross-Sectional Study.

Atrophy Patterns of Hippocampal Subfields in T2DM Patients with Cognitive Impairment

Irreversible atrophy in memory brain regions over 7 years is predicted by glycemic control in type 2 diabetes without mild cognitive impairment

Type 2 diabetes is associated with increased risk of dementia, but not mild cognitive impairment: a cross-sectional study among the elderly in Chinese communities

Structural and functional alterations of the hippocampal subfields in T2DM with mild cognitive impairment and insulin resistance: A prospective study